Back to trial detailsIntake questionnaire
Lorlatinib Plus Local Consolidation Therapy In ALK Positive Advanced Non-Small Cell Lung Cancer
Applying to The University of Texas M. D. Anderson Cancer Center · Houston, Texas
Answer a few short questions to share with the research team.
0 of 4 answered